Zobrazeno 1 - 10
of 77
pro vyhledávání: '"Toru Tateno"'
Publikováno v:
Frontiers in Endocrinology, Vol 15 (2024)
Externí odkaz:
https://doaj.org/article/5fca28cab9f74fbcbde28a4ca4164bdb
Publikováno v:
Endocrinology and Metabolism, Vol 38, Iss 6, Pp 631-654 (2023)
Pituitary neuroendocrine tumors (PitNETs) are the third most frequently diagnosed intracranial tumors, with nonfunctioning PitNETs (nfPitNETs) accounting for 30% of all pituitary tumors and representing the most common type of macroPitNETs. NfPitNETs
Externí odkaz:
https://doaj.org/article/40ffe20336ac4239a1026400b3d54d46
Autor:
Tae Nakano-Tateno, Kheng Joe Lau, Justin Wang, Cailin McMahon, Yasuhiko Kawakami, Toru Tateno, Takako Araki
Publikováno v:
Frontiers in Endocrinology, Vol 12 (2021)
Up to 35% of aggressive pituitary tumors recur and significantly affect mortality and quality of life. Management can be challenging and often requires multimodal treatment. Current treatment options, including surgery, conventional medical therapies
Externí odkaz:
https://doaj.org/article/3ad90c9065a444ceac4e3c5dd9d52e87
Autor:
Shawn M Lamothe, Nazlee Sharmin, Grace Silver, Motoyasu Satou, Yubin Hao, Toru Tateno, Victoria A Baronas, Harley T Kurata
Publikováno v:
eLife, Vol 9 (2020)
Many voltage-dependent ion channels are regulated by accessory proteins. We recently reported powerful regulation of Kv1.2 potassium channels by the amino acid transporter Slc7a5. In this study, we report that Kv1.1 channels are also regulated by Slc
Externí odkaz:
https://doaj.org/article/f521d5e399a34766b3968684f92f7f68
Autor:
Masahiro Nezu, Yosuke Hirotsu, Kenji Amemiya, Toru Tateno, Soichi Takizawa, Masaharu Inoue, Hitoshi Mochizuki, Kyoko Hosaka, Chik, Constance, Toshio Oyama, Masao Omata
Publikováno v:
Internal Medicine; 2023, Vol. 62 Issue 13, p1895-1905, 11p
Autor:
Noriaki Tanabe, Naoko Inoshita, Atsushi Ishida, Masataka Kato, Haruko Yoshimoto, Hideki Shiramizu, Hidetaka Suga, Toru Tateno, Kenichi Ohashi, Shozo Yamada
Touch imprint cytological (TIC) preparation and frozen section (FS) procedures are essential for intraoperative pathological diagnosis (IPD). They are invaluable tools for therapeutic decision-making, helping surgeons avoid under or overtreatment of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a79edbba6c0fd088d50036b72ce05c37
https://doi.org/10.21203/rs.3.rs-2897256/v1
https://doi.org/10.21203/rs.3.rs-2897256/v1
Autor:
Takako Araki, Hiraku Kameda, Masaaki Yamamoto, Toru Tateno, Yasumasa Iwasaki, Run Yu, Constance Chik, Hiba Hashmi, Angela Radulescu, Lynn A Burmeister, Hidenori Fukuoka
Publikováno v:
Journal of the Endocrine Society, vol 7, iss 4
ContextThe COVID-19 pandemic challenged undertaking gradual educational activities for residency and fellowship trainees. However, recent technological advances have enabled broadening active learning opportunities through international online confer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::369096c6fd8a74a9d522b7ea2543fd1c
https://hdl.handle.net/20.500.14094/0100480930
https://hdl.handle.net/20.500.14094/0100480930
Publikováno v:
Endocrine Journal. 68:1143-1153
Pituitary adenomas are benign tumours that can cause an individual various clinical manifestations including tumour mass effects and/or the diverse effects of abnormal pituitary hormone secretion. Given the morbidity and limited treatment options for
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::be71e034c29a71916e272f5be638ad92
https://doi.org/10.1507/endocrj.ej21-0106
https://doi.org/10.1507/endocrj.ej21-0106
Autor:
Jay Easaw, Naoko Inoshita, Tae Nakano-Tateno, Frank van Landeghem, Constance L. Chik, Toru Tateno, Motoyasu Satou, Vivek Mehta
Publikováno v:
Endocrine Pathology. 32:418-426
Corticotroph carcinomas and aggressive corticotroph tumors can be resistant to conventional therapy, including surgery, radiotherapy, and medical treatment. Recent evidence suggests that temozolomide (an oral alkylating agent) administered with capec
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bbfc4e1c079935a29744423991846b11
https://doi.org/10.1007/s12022-020-09647-w
https://doi.org/10.1007/s12022-020-09647-w
Publikováno v:
Journal of the Endocrine Society. 6:A479-A479
Introduction Pituitary tumors (PTs) occur in almost 17% of the population and they represent about 10% of all intracranial tumors. At present, many patients with pituitary tumors suffer from symptoms and complications caused by abnormal hormone produ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2eb8f6c0a9306a75f69051e015a99168
https://doi.org/10.1210/jendso/bvac150.994
https://doi.org/10.1210/jendso/bvac150.994